The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Overall venture funding, as well as “first financing” rounds, fell significantly in the second quarter, erasing what had been ...

On a conference call, CEO Doug Ingram said the decision to cut 36% of the company's staff and halt several drug programs was ...

Quarterly pharmaceutical sales surpassed $15 billion for the first time as strong performance from J&J's cancer medicines ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

The results position Hengrui to seek approval of the Zepbound-like drug in China, and Kailera, a well-funded startup, to ...

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

Sino Biopharmaceuticals plans to pay up to $950.9 million to acquire LaNova Medicines, which previously licensed drugs to ...

Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...

NHS England agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced a once-monthly PrEP pill ...